Login
← Go Back
Onesource Specialty Pharma
ONESOURCE · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 24, 2025
Stock Price vs Company Growth
1d
0.3%
1w
4.8%
1m
35.8%
3m
62.3%
6m
2.7%
1y
13.9%
all
5.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,823 0.3%
1,134
1,870
Company Overview
Sales
1,419 Cr
Growth: 49.5%
Profit after Tax
20.1 Cr
Growth: -49.7%
Mid Cap
20,895 Cr
P/E: 1013.2x
Industry P/E: 30.4x
Fundamentals
Sales (Cr) ₹ 1,419
Growth 49.5%
EBITDA 27.8%
P/S 14.7x
Dividend 0.0%
P/E 1013.2x
Book Value ₹ 506
PEG Ratio 20.5x
ROE 0.3%
P/B 3.6x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
OneSource Specialty Pharma is evolved into an integrated, multimodal specialty pharmaceutical CDMO. The company specialises in offering end-to-end solutions across biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatin capsules).Awards2024-25OneSource received the Sustainable Organisation Award 2025 at the 5th Sustainability Summit hosted by UBS Forums on June 11, 2025 in Gurgaon.Received ESG award in gold category from OHSSAI Foundation.
Belongs to (22 Indices) view more